Interaction of variable bacterial outer membrane lipoproteins with brain endothelium

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Gandhi, Gaurav ^b   Londoño, Diana ^a,b   Whetstine, Christine R ^c   Sethi, Nilay ^b   Kim, Kwang S ^d   Zückert, Wolfram R ^c   Cadavid, Diego ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL OUTER MEMBRANE LIPOPROTEIN VSP1; BACTERIAL PROTEIN; LANTHANIDE; LIPOPROTEIN; UNCLASSIFIED DRUG; OUTER MEMBRANE PROTEIN; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; BORRELIA BURGDORFERI; BRAIN BLOOD VESSEL; BRAIN TISSUE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TEMPERATURE; INOCULATION; ISOTOPE LABELING; LOW TEMPERATURE; MOUSE; NONHUMAN; PROTEIN INTERACTION; PROTEIN TRANSPORT; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; CELL CULTURE; CYTOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; VASCULARIZATION;

BACTERIA (MICROORGANISMS); BORRELIA BURGDORFERI; BORRELIA TURICATAE; MUS; SPIROCHAETALES;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BASE SEQUENCE; BLOOD-BRAIN BARRIER; BORRELIA BURGDORFERI; BRAIN; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIUM, VASCULAR; LIPOPROTEINS; MICE;

EID: 78149439726     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013257     Document Type: Article

References (67)

1. Londono D, Cadavid D(2010)BacterialLipoproteinsCanDisseminatefromthe Periphery to Inflame the Brain. Am J Pathol 176: 2848-57.
2. Cadavid D, Garcia E, Gelderblom H (2007) Coinfection with Borrelia turicatae serotype 2 prevents the severe vestibular dysfunction and earlier mortality caused by serotype 1. J Infect Dis 195: 1686-93.
3. Cadavid D, Pachner AR, Estanislao L, Patalapati R, Barbour AG (2001) Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun 69: 3389-97.
4. Cadavid D, Sondey M, Garcia E, Lawson CL (2006) Residual brain infection in relapsing-fever borreliosis. J Infect Dis 193: 1451-8.
5. Cadavid D, Thomas DD, Crawley R, Barbour AG (1994) Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med 179: 631-42.
6. Gelderblom H, Londono D, Bai Y, Cabral ES, Quandt J, et al. (2007) High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatae. J Neuropathol Exp Neurol 66: 208-17.
7. Gelderblom H, Schmidt J, Londono D, Bai Y, Quandt J, et al. (2007) Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae. Am J Pathol 170: 251-62.
8. Londoño D, Carvajal J, Arguelles-Grande C, Marques A, Cadavid D (2008) Interleukin 10 protects the brain microcirculation from spirochetal injury.J Neuropathol Exp Neurol 67: 976-83.
9. Londoño D, Marques A, Hornung RL, Cadavid D (2008) IL-10 helps control pathogen load during high-level bacteremia. J Immunol 181: 2076-83.
10. Sethi N, Sondey M, Bai Y, Kim KS, Cadavid D (2006) Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system. Infect Immun 74: 6408-18.
11. Zuckert WR, Lloyd JE, Stewart PE, Rosa PA, Barbour AG (2004) Cross-species surface display of functional spirochetal lipoproteins by recombinant Borrelia burgdorferi. Infect Immun 72: 1463-9.
12. Zambrano MC, Beklemisheva AA, Bryksin AV, Newman SA, Cabello FC (2004) Borrelia burgdorferi binds to, invades, and colonizes native type I collagen lattices. Infect Immun 72: 3138-46.
13. Magoun L, Zuckert WR, Robbins D, Parveen N, Alugupalli KR, et al. (2000) Variable small protein (Vsp)-dependent and Vsp-independent pathways for glycosaminoglycan recognition by relapsing fever spirochaetes. Mol Microbiol 36: 886-97.
14. Kawabata H, Norris SJ, Watanabe H (2004) BBE02 disruption mutants of Borrelia burgdorferi B31 have a highly transformable, infectious phenotype. Infect Immun 72: 7147-54.
15. Cadavid D, Pennington PM, Kerentseva TA, Bergstrom S, Barbour AG (1997) Immunologic and genetic analyses of VmpA of a neurotropic strain of Borrelia turicatae. Infect Immun 65: 3352-60.
16. Pennington PM, Cadavid D, Bunikis J, Norris SJ, Barbour AG (1999) Extensive interplasmidic duplications change the virulence phenotype of the relapsing fever agent Borrelia turicatae. Mol Microbiol 34: 1120-32.
17. Schlachetzki F, Zhu C, Pardridge WM (2002) Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier. J Neurochem 81: 203-6.
18. Mehra R, Londono D, Sondey M, Lawson C, Cadavid D (2009) Structure-function investigation of vsp serotypes of the spirochete Borrelia hermsii. PLoS One 4: e7597.
19. Diamandis EP, Christopoulos TK (1990) Europium chelate labels in time-resolved fluorescence immunoassays and DNA hybridization assays. Anal Chem 62: 1149A-1157A.
20. Ivey NS, Martin EN, Jr., Scheld WM, Nathan BR (2005) A new method for measuring blood-brain barrier permeability demonstrated with Europium-bound albumin during experimental lipopolysaccharide (LPS) induced menin-gitis in the rat. J Neurosci Methods 142: 91-5.
21. Prasadarao NV, Wass CA, Weiser JN, Stins M, Huang SH, et al. (1999) Identification and characterization of a novel Ibe10 binding protein that contributes to Escherichia coli invasion of brain microvascular endothelial cells. Infect Immun 67: 1131-38.
22. Prasadarao NV, Wass CA, Stins MF, Shimada H, Kim KS (1999) Outer membrane protein A-promoted actin condensation of brain microvascular endothelial cells is required for Escherichia coli invasion. Infect Immun 67:5775-83.
23. Grab DJ, Perides G, Dumler JS, Kim KJ, Park J, et al. (2005) Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect Immun 73: 1014-22.
24. Carter CJ, Bergstrom S, Norris SJ, Barbour AG (1994) A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia. Infect Immun 62:2792-9.
25. Kumaran D, Eswaramoorthy S, Luft BJ, Koide S, Dunn JJ, et al. (2001) Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi. Embo J 20: 971-8.
26. Lawson CL, Yung BH, Barbour AG, Zuckert WR (2006) Crystal structure of neurotropism-associated variable surface protein 1 (Vsp1) of Borrelia turicatae. J Bacteriol 188: 4522-30.
27. Thomas DD, Cadavid D, Barbour AG (1994) Differential association of Borrelia species with cultured neural cells. J Infect Dis 169: 445-8.
28. Goldstein J, Basu S, Brown M (1983) Methods Enzymol 98: 241-260.
29. Bunikis J, Mirian H, Bunikiene E, Barbour AG (2001) Non-heritable change of a spirochaete's phenotype by decoration of the cell surface with exogenous lipoproteins. Mol Microbiol 40: 387-96.
30. Londoño D, Bai Y, Zuckert WR, Gelderblom H, Cadavid D (2005) Cardiac apoptosis in severe relapsing fever borreliosis. Infect Immun 73: 7669-76.
31. Cadavid D (2006) The mammalian host response to borrelia infection. Wien Klin Wochenschr 118: 653-8.
32. Zuckert WR, Kerentseva TA, Lawson CL, Barbour AG (2001) Structural conservation of neurotropism-associated VspA within the variable Borrelia Vsp-OspC lipoprotein family. J Biol Chem 276: 457-63.
33. Baron C, Thorstenson YR, Zambryski PC (1997) The lipoprotein VirB7 interacts with VirB9 in the membranes of Agrobacterium tumefaciens. J Bacteriol 179: 1211-8.
34. Pennington PM, Cadavid D, Barbour AG (1999) Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice. Infect Immun 67: 4637-45.
35. Cadavid D (2010) Spirochetal infections. Handb Clin Neurol 96: 179-219.
36. Cadavid D, Barbour AG (1998) Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis 26: 151-64.
37. Cadavid D, Londono D (2009) Understanding tropism and immunopathological echanisms of relapsing fever spirochaetes. Clin Microbiol Infect 15: 415-21.
38. Nassif X, Bourdoulous S, Eugene E, Couraud PO (2002) How do extracellular pathogens cross the blood-brain barrier? Trends Microbiol 10: 227-32.
39. Sadziene A, Thomas DD, Barbour AG (1995) Borrelia burgdorferi mutant lacking Osp: biological and immunological characterization. Infect Immun 63:1573-80.
40. Antonara S, Chafel RM, LaFrance M, Coburn J (2007) Borrelia burgdorferi adhesins identified using in vivo phage display. Mol Microbiol 66: 262-76.
41. Guo BP, Brown EL, Dorward DW, Rosenberg LC, Hook M (1998) Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol 30: 711-23.
42. Coburn J, Leong JM, Erban JK (1993) Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci U S A 90: 7059-63.
43. Garcia Monco JC, Fernandez Villar B, Rogers RC, Szczepanski A, Wheeler CM, et al. (1992) Borrelia burgdorferi and other related spirochetes bind to galactocerebroside. Neurology 42: 1341-8.
44. Guo BP, Norris SJ, Rosenberg LC, Hook M (1995) Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect Immun 63: 3467-72.
45. Leong JM, Wang H, Magoun L, Field JA, Morrissey PE, et al. (1998) Different classes of proteoglycans contribute to the attachment of Borrelia burgdorferi to cultured endothelial and brain cells. Infect Immun 66: 994-9.
46. Norman MU, Moriarty TJ, Dresser AR, Millen B, Kubes P, et al. (2008) Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog 4: e1000169.
47. Comstock LE, Thomas DD (1991) Characterization of Borrelia burgdorferi invasion of cultured endothelial cells. Microb Pathog 10: 137-48.
48. Thomas DD, Comstock LE (1989) Interaction of Lyme disease spirochetes with cultured eucaryotic cells. Infect Immun 57: 1324-6.
49. Comstock LE, Thomas DD (1989) Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect Immun 57: 1626-8.
50. Szczepanski A, Furie MB, Benach JL, Lane BP, Fleit HB (1990) Interaction between Borrelia burgdorferi and endothelium in vitro. J Clin Invest 85: 1637-47.
51. Ma Y, Sturrock A, Weis JJ (1991) Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect Immun 59: 671-8.
52. Sellati TJ, Abrescia LD, Radolf JD, Furie MB (1996) Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect Immun 64:3180-7.
53. Sellati TJ, Burns MJ, Ficazzola MA, Furie MB (1995) Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect Immun 63: 4439-47.
54. Burns MJ, Sellati TJ, Teng EI, Furie MB (1997) Production of interleukin-8 (IL-8) by cultured endothelial cells in response to Borrelia burgdorferi occurs independently of secreted [corrected] IL-1 and tumor necrosis factor alpha and is required for subsequent transendothelial migration of neutrophils. Infect Immun 65: 1217-22.
55. Shamaei-Tousi A, Burns MJ, Benach JL, Furie MB, Gergel EI, et al. (2000) The relapsing fever spirochaete, Borrelia crocidurae, activates human endothelial cells and promotes the transendothelial migration of neutrophils. Cell Microbiol 2: 591-9.
56. Gergel EI, Furie MB (2001) Activation of endothelium by Borrelia burgdorferi in vitro enhances transmigration of specific subsets of T lymphocytes. Infect Immun 69: 2190-7.
57. Lisinski TJ, Furie MB (2002) Interleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burgdorferi or lipopolysaccharide but not interleukin-1beta or tumor necrosis factor alpha. J Leukoc Biol 72: 503-11.
58. Dame TM, Orenzoff BL, Palmer LE, Furie MB (2007) IFN-gamma alters the response of Borrelia burgdorferi-activated endothelium to favor chronic inflammation. J Immunol 178: 1172-9.
59. Stewart PE, Thalken R, Bono JL, Rosa P (2001) Isolation of a circular plasmid region sufficient for autonomous replication and transformation of infectious Borrelia burgdorferi. Mol Microbiol 39: 714-721.
60. Elias AF, Stewart PE, Grimm D, Caimano MJ, Eggers CH, et al. (2002) Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background. Infect Immun 70: 2139-50.
61. Samuels DS (1995) Electrotransformation of the spirochete Borrelia burgdorferi. Methods Mol Biol 47: 253-9.
62. Labandeira-Rey M, Skare JT (2001) Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1. Infect Immun 69: 446-55.
63. Purser JE, Lawrenz MB, Caimano MJ, Howell JK, Radolf JD, et al. (2003) A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Mol Microbiol 48: 753-64.
64. Barbour AG, Schrumpf ME (1986) Polymorphisms of major surface proteins of Borrelia burgdorferi. Zentralbl Bakteriol Mikrobiol Hyg [A] 263: 83-91.
65. Hara H, Lamon KD, Kaji H (1981) Effect of temperature on normal and SV40-transformed human fibroblasts. Biochim Biophys Acta 673: 37-45.
66. Yazaki T, Manz HJ, Rabkin SD, Martuza RL (1995) Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1. Cancer Res 55: 4752-6.
67. Salazar JC, Pope CD, Moore MW, Pope J, Kiely TG, et al. (2005) Lipoprotein- dependent and -independent immune responses to spirochetal infection. Clin Diagn Lab Immunol 12:949-58.